Madrigal Pharmaceuticals (MDGL) EBITDA (2010 - 2026)
Madrigal Pharmaceuticals' EBITDA came in at -$55.93 million for Q2 2026, compared with -$46.83 million a year earlier.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Madrigal Pharmaceuticals reported EBITDA of -$321.1 million; for FY2025, it came in at -$298.59 million.
- Going back by year, EBITDA was -$496.78 million in FY2024, -$379.97 million in FY2023, -$293.1 million in FY2022 and -$242.08 million in FY2021.
- The five-year range for quarterly EBITDA is -$162.27 million (Q2 2024) to -$46.83 million (Q2 2025).
- Business Quant data shows MDGL's EBITDA at -$92.34 million (Q1 2026), -$59.22 million (Q4 2025) and -$113.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Madrigal Pharmaceuticals | 13.67 Bn | 9.93 Bn | - | -55.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.46 Mn |
| Mar 31, 2026 | -91.89 Mn |
| Dec 31, 2025 | -58.75 Mn |
| Sep 30, 2025 | -113.29 Mn |
| Jun 30, 2025 | -46.45 Mn |
| Mar 31, 2025 | -78.50 Mn |
| Dec 31, 2024 | -66.15 Mn |
| Sep 30, 2024 | -115.53 Mn |
| Jun 30, 2024 | -161.80 Mn |
| Mar 31, 2024 | -151.21 Mn |
| Dec 31, 2023 | -116.28 Mn |
| Sep 30, 2023 | -97.73 Mn |
| Jun 30, 2023 | -85.77 Mn |
| Mar 31, 2023 | -77.78 Mn |
| Dec 31, 2022 | -84.86 Mn |
| Sep 30, 2022 | -79.98 Mn |
| Jun 30, 2022 | -69.99 Mn |
| Mar 31, 2022 | -57.48 Mn |
| Dec 31, 2021 | -64.50 Mn |
| Sep 30, 2021 | -63.06 Mn |
API Access
Madrigal Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();